These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20660507)

  • 1. FDA puts rosiglitazone post-marketing trial on hold.
    Cohen D
    BMJ; 2010 Jul; 341():c4017. PubMed ID: 20660507
    [No Abstract]   [Full Text] [Related]  

  • 2. Rosiglitazone, marketing, and medical science.
    Moynihan R
    BMJ; 2010 Apr; 340():c1848. PubMed ID: 20375091
    [No Abstract]   [Full Text] [Related]  

  • 3. Rosiglitazone: what went wrong?
    Cohen D
    BMJ; 2010 Sep; 341():c4848. PubMed ID: 20819889
    [No Abstract]   [Full Text] [Related]  

  • 4. The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience.
    Hiatt WR; Kaul S; Smith RJ
    N Engl J Med; 2013 Oct; 369(14):1285-7. PubMed ID: 23992603
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary: What can we learn from the continuing regulatory focus on the thiazolidinediones?
    Freemantle N
    BMJ; 2010 Sep; 341():c4812. PubMed ID: 20819888
    [No Abstract]   [Full Text] [Related]  

  • 6. The rosiglitazone decision process at FDA and EMA. What should we learn?
    Pouwels KB; van Grootheest K
    Int J Risk Saf Med; 2012; 24(2):73-80. PubMed ID: 22751189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA advisers recommend new controls on rosiglitazone use.
    Traynor K
    Am J Health Syst Pharm; 2010 Aug; 67(16):1306-8. PubMed ID: 20689113
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA hearings leave doctors, patients in limbo on Avandia.
    Eggertson L; Woodward C
    CMAJ; 2010 Sep; 182(12):E559-60. PubMed ID: 20660583
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA on rosiglitazone. More on advisory committee decision.
    Graham DJ; Gelperin K
    BMJ; 2010 Sep; 341():c4868. PubMed ID: 20823021
    [No Abstract]   [Full Text] [Related]  

  • 10. The painful truth.
    Nissen SE
    Eur Heart J; 2010 May; 31(10):1284-5. PubMed ID: 20418344
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosiglitazone: failure of oversight or demons imagined?
    Susman J
    J Fam Pract; 2007 Sep; 56(9):696, 703. PubMed ID: 17764640
    [No Abstract]   [Full Text] [Related]  

  • 12. The rosiglitazone story--lessons from an FDA Advisory Committee meeting.
    Rosen CJ
    N Engl J Med; 2007 Aug; 357(9):844-6. PubMed ID: 17687124
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA committee urges tight restrictions on rosiglitazone.
    Roehr B
    BMJ; 2010 Jul; 341():c3862. PubMed ID: 20639290
    [No Abstract]   [Full Text] [Related]  

  • 14. Rosiglitazone and implications for pharmacovigilance.
    Kazi D
    BMJ; 2007 Jun; 334(7606):1233-4. PubMed ID: 17569897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA puts restrictions on use of controversial diabetes drug.
    Mayo Clin Womens Healthsource; 2011 Feb; 15(2):3. PubMed ID: 21200371
    [No Abstract]   [Full Text] [Related]  

  • 16. Revisiting the rosiglitazone story--lessons learned.
    Rosen CJ
    N Engl J Med; 2010 Aug; 363(9):803-6. PubMed ID: 20660395
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical consequences of disseminating the rosiglitazone FDA safety warning.
    Orrico KB; Lin JK; Wei A; Yue H
    Am J Manag Care; 2010 May; 16(5):e111-6. PubMed ID: 20455636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The truth about rosiglitazone (avandia).
    Ledbetter C; Laustsen G
    Nurse Pract; 2008 Jun; 33(6):10-1. PubMed ID: 18528195
    [No Abstract]   [Full Text] [Related]  

  • 19. European drug regulators publish their evaluation of rosiglitazone.
    Mayor S
    BMJ; 2010 Dec; 341():c7278. PubMed ID: 21169326
    [No Abstract]   [Full Text] [Related]  

  • 20. Rosiglitazone and the need for a new drug safety agency.
    Garattini S; Bertele' V
    BMJ; 2010 Oct; 341():c5506. PubMed ID: 20926483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.